Bin Li
- Cancer Research top 2%
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 17
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine 12
- Neurology top 2%
- Immunology top 5%
- Immune Response and Inflammation 12
- Molecular Biology top 2%
- Circular RNAs in diseases 18
- Inflammasome and immune disorders 17
-
- Autophagy in Disease and Therapy 20
-
- Multiple Sclerosis Research Studies 14
- Co-authors
- Yu HuangXingxuan HeCheng‐Xin GongEdward H. SchuchmanLi GuoWei CuiMeixi LiHongmin Bai
- Journals
- Journal of Neuroimmunology (7 papers)Scientific Reports (7 papers)Frontiers in Immunology (6 papers)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Bin Li
255 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 148
- Cancer Research 796
- Geriatrics and Gerontology 175
- Neurology 340
- Immunology 818
- Molecular Biology 2.6k
Countries citing papers authored by Bin Li
This map shows the geographic impact of Bin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Li more than expected).
Fields of papers citing papers by Bin Li
This network shows the impact of papers produced by Bin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Li. The network helps show where Bin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 9 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 17 | |
| 15 | 2020 | 17 | |
| 16 | 2018 | 5 | |
| 17 | 2017 | 85 | |
| 18 | 2017 | 22 | |
| 19 | 2014 | 69 | |
| 20 | 2008 | 46 |
About Bin Li
Bin Li is a scholar working on Geriatrics and Gerontology, Immunology, Cancer Research, Epidemiology and Molecular Biology, having authored 271 papers that have together received 5.2k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (20 papers), Circular RNAs in diseases (18 papers), MicroRNA in disease regulation (17 papers), Inflammasome and immune disorders (17 papers), Cancer-related molecular mechanisms research (17 papers), Multiple Sclerosis Research Studies (14 papers), Immune Response and Inflammation (12 papers) and Sirtuins and Resveratrol in Medicine (12 papers). The work is most often cited by research in Cancer Research (796 citations), Geriatrics and Gerontology (175 citations), Neurology (340 citations), Immunology (818 citations) and Molecular Biology (2.6k citations). Bin Li has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Yu Huang, Xingxuan He, Cheng‐Xin Gong, Edward H. Schuchman, Li Guo, Wei Cui, Meixi Li, Hongmin Bai, Jing Zhang and Ye Cheng. Their work appears in journals such as Journal of Neuroimmunology, Scientific Reports, Frontiers in Immunology, International Immunopharmacology and Frontiers in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.